Under current recommendations, people who use cannabis for conditions including chronic pain, arthritis, the side effects of chemotherapy and even the self-medication of brain and other tumours, will continue to be criminalised.
The cannabis industry has largely escaped negligence cases to date, mainly due to legal uncertainties - experts claim this ‘tort cease-fire’ is coming to an end.
In Colorado and Washington arrest rates for cannabis has fallen and crime clearance rates for violent crime, burglary, motor vehicle theft and property crime have shifted upward.
Preventive steps and remediative action are required to reduce the prevalence of contamination from microbes, heavy metals and, pesticides.
The market for cannabis and hemp products has seen a low-key but potentially huge step forward in recent weeks.
Reviews of scientific evidence show promising findings for some, but not all, conditions for which cannabis is considered a treatment – and this evidence is difficult to untangle.
GB Sciences are looking for international suppliers that produce minor cannabinoids and terpenes to ensure that it can expand testing beyond their planned, initial Phase 0 Trial.